Current perspectives therapeutic approach in patients with stable angina

Maddalena Lettino, Colomba Falcone, Luigi Tavazzi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Which therapeutic strategy among medical, interventional and surgical options should be preferred in patients with chronic stable ischemic heart disease is an important public health problem. The available scientific evidence does not help much to facilitate the choice among the three available strategies of medical treatment, percutaneous coronary intervention and coronary artery bypass grafting. In this area practice-based medicine overwhelms evidence-based medicine. However, existing findings are discussed. The present experience in diabetic patients is highlighted; in such patients surgery is generally recommended but the results obtained by percutaneous coronary intervention with the currently available tools are improving markedly. Pharmacological therapy is also improving, particularly in the prevention of the progression of atherothrombosis and consequently of cardiovascular events. Actually two categories of drugs should be recognized: those prescribed to prevent death and myocardial infarction and those with antianginal and anti-ischemic effects aimed at alleviating symptoms and reducing ischemia. The first group of drugs includes antiplatelet-antithrombotic agents, lipid-lowering agents and angiotensin-converting enzyme inhibitors; the second group includes beta-blockers, calcium antagonists and nitrates. A good integration of the two classes of drugs, combined with an appropriate use of coronary revascularization procedures, should yield the maximum possible benefit in the individual patient.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalItalian Heart Journal
Volume6
Issue number1
Publication statusPublished - Jan 2005

Fingerprint

Stable Angina
Percutaneous Coronary Intervention
Pharmaceutical Preparations
Fibrinolytic Agents
Evidence-Based Medicine
Platelet Aggregation Inhibitors
Therapeutics
Angiotensin-Converting Enzyme Inhibitors
Coronary Artery Bypass
Myocardial Ischemia
Ischemia
Public Health
Myocardial Infarction
Pharmacology
Lipids

Keywords

  • Angina
  • Coronary artery disease
  • Revascularization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Current perspectives therapeutic approach in patients with stable angina. / Lettino, Maddalena; Falcone, Colomba; Tavazzi, Luigi.

In: Italian Heart Journal, Vol. 6, No. 1, 01.2005, p. 1-8.

Research output: Contribution to journalArticle

Lettino, Maddalena ; Falcone, Colomba ; Tavazzi, Luigi. / Current perspectives therapeutic approach in patients with stable angina. In: Italian Heart Journal. 2005 ; Vol. 6, No. 1. pp. 1-8.
@article{bec400e0621c4591b599f2e4b899ec55,
title = "Current perspectives therapeutic approach in patients with stable angina",
abstract = "Which therapeutic strategy among medical, interventional and surgical options should be preferred in patients with chronic stable ischemic heart disease is an important public health problem. The available scientific evidence does not help much to facilitate the choice among the three available strategies of medical treatment, percutaneous coronary intervention and coronary artery bypass grafting. In this area practice-based medicine overwhelms evidence-based medicine. However, existing findings are discussed. The present experience in diabetic patients is highlighted; in such patients surgery is generally recommended but the results obtained by percutaneous coronary intervention with the currently available tools are improving markedly. Pharmacological therapy is also improving, particularly in the prevention of the progression of atherothrombosis and consequently of cardiovascular events. Actually two categories of drugs should be recognized: those prescribed to prevent death and myocardial infarction and those with antianginal and anti-ischemic effects aimed at alleviating symptoms and reducing ischemia. The first group of drugs includes antiplatelet-antithrombotic agents, lipid-lowering agents and angiotensin-converting enzyme inhibitors; the second group includes beta-blockers, calcium antagonists and nitrates. A good integration of the two classes of drugs, combined with an appropriate use of coronary revascularization procedures, should yield the maximum possible benefit in the individual patient.",
keywords = "Angina, Coronary artery disease, Revascularization",
author = "Maddalena Lettino and Colomba Falcone and Luigi Tavazzi",
year = "2005",
month = "1",
language = "English",
volume = "6",
pages = "1--8",
journal = "Italian Heart Journal",
issn = "1129-471X",
publisher = "Societa Italiana di Cardiologia",
number = "1",

}

TY - JOUR

T1 - Current perspectives therapeutic approach in patients with stable angina

AU - Lettino, Maddalena

AU - Falcone, Colomba

AU - Tavazzi, Luigi

PY - 2005/1

Y1 - 2005/1

N2 - Which therapeutic strategy among medical, interventional and surgical options should be preferred in patients with chronic stable ischemic heart disease is an important public health problem. The available scientific evidence does not help much to facilitate the choice among the three available strategies of medical treatment, percutaneous coronary intervention and coronary artery bypass grafting. In this area practice-based medicine overwhelms evidence-based medicine. However, existing findings are discussed. The present experience in diabetic patients is highlighted; in such patients surgery is generally recommended but the results obtained by percutaneous coronary intervention with the currently available tools are improving markedly. Pharmacological therapy is also improving, particularly in the prevention of the progression of atherothrombosis and consequently of cardiovascular events. Actually two categories of drugs should be recognized: those prescribed to prevent death and myocardial infarction and those with antianginal and anti-ischemic effects aimed at alleviating symptoms and reducing ischemia. The first group of drugs includes antiplatelet-antithrombotic agents, lipid-lowering agents and angiotensin-converting enzyme inhibitors; the second group includes beta-blockers, calcium antagonists and nitrates. A good integration of the two classes of drugs, combined with an appropriate use of coronary revascularization procedures, should yield the maximum possible benefit in the individual patient.

AB - Which therapeutic strategy among medical, interventional and surgical options should be preferred in patients with chronic stable ischemic heart disease is an important public health problem. The available scientific evidence does not help much to facilitate the choice among the three available strategies of medical treatment, percutaneous coronary intervention and coronary artery bypass grafting. In this area practice-based medicine overwhelms evidence-based medicine. However, existing findings are discussed. The present experience in diabetic patients is highlighted; in such patients surgery is generally recommended but the results obtained by percutaneous coronary intervention with the currently available tools are improving markedly. Pharmacological therapy is also improving, particularly in the prevention of the progression of atherothrombosis and consequently of cardiovascular events. Actually two categories of drugs should be recognized: those prescribed to prevent death and myocardial infarction and those with antianginal and anti-ischemic effects aimed at alleviating symptoms and reducing ischemia. The first group of drugs includes antiplatelet-antithrombotic agents, lipid-lowering agents and angiotensin-converting enzyme inhibitors; the second group includes beta-blockers, calcium antagonists and nitrates. A good integration of the two classes of drugs, combined with an appropriate use of coronary revascularization procedures, should yield the maximum possible benefit in the individual patient.

KW - Angina

KW - Coronary artery disease

KW - Revascularization

UR - http://www.scopus.com/inward/record.url?scp=58149333829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149333829&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:58149333829

VL - 6

SP - 1

EP - 8

JO - Italian Heart Journal

JF - Italian Heart Journal

SN - 1129-471X

IS - 1

ER -